Liposic (Carbomer)

Carbomer is a high‑molecular‑weight acrylic polymer that swells in water to create a gel matrix. This matrix thickens the solution, providing a consistent viscosity that keeps active ingredients evenly dispersed and protects them from degradation, thereby enhancing drug delivery to the eye.

The dosage of Liposic is determined by the prescribing ophthalmologist or pharmacist based on the specific eye drop formulation and the patient’s clinical needs. The prescriber sets the appropriate concentration and volume for each individual case.

Carbomer is generally considered to have low systemic absorption when applied to the eye, but safety data for use during pregnancy or lactation are limited. Healthcare providers should evaluate the risk‑benefit profile for each patient and consider alternative options if uncertainty exists.

To order Liposic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with other ophthalmic vehicles, carbomer offers superior viscosity control and gel stability, which can improve the uniformity of active ingredient distribution. Some alternatives, such as hyaluronic acid or methylcellulose, may provide different rheological properties, but carbomer is widely valued for its consistency and ease of formulation.

Liposic should be stored at room temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its viscosity and sterility.

Liposic is administered as an ophthalmic solution. The prescribed eye drops are instilled into the conjunctival sac of the affected eye(s) using the recommended technique, typically by gently pulling down the lower eyelid and applying the drop without touching the bottle tip to the eye.

The most serious risks include severe allergic reactions such as anaphylaxis, corneal ulceration, and significant increases in intra‑ocular pressure. Patients should be monitored for any signs of these events, and immediate medical attention is required if they occur.

Individuals with a known hypersensitivity to carbomer or any component of the formulation should avoid using Liposic. Additionally, patients with active corneal infections or severe ocular surface disease should consult an eye care professional before use.